U.S. Health Secretary Robert F. Kennedy Jr. has named eight new members to the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP), following the abrupt dismissal of all 17 prior members. The newly appointed panel includes several figures known for expressing skepticism about vaccines, particularly mRNA technology.
Among the new appointees is Robert Malone, a vocal critic of mRNA COVID-19 vaccines and an ally of Kennedy’s "Make America Healthy Again" movement. Other members include Joseph Hibbeln, Martin Kulldorff, Retsef Levi, Cody Meissner, James Pagano, Vicky Pebsworth, and Michael Ross—some of whom have ties to prior CDC or FDA vaccine panels, while others have promoted views critical of current vaccination practices.
Kennedy, who has long challenged vaccine safety despite scientific consensus, claimed the former panel had conflicts of interest, although he did not provide specific evidence. He emphasized the reshuffle was meant to “restore public trust in vaccine science.”
The new ACIP members will participate in the committee’s June 25–27 meeting, where decisions are expected on vaccine recommendations for flu shots and the 2025–26 COVID-19 boosters. The meeting agenda has yet to be released.
The move sparked market reactions: Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE) shares dipped slightly, while Novavax (NASDAQ:NVAX), which produces a non-mRNA COVID-19 vaccine, saw a marginal rise.
Concerns remain about the vetting process for the new members. Some, like Pebsworth and Meissner, have served on FDA advisory committees, while others, such as Levi and Kulldorff, have made controversial statements questioning mRNA vaccine safety.
Despite FDA confirmation that mRNA vaccines are safe and effective, Kennedy’s overhaul has intensified the national debate on vaccine policy and public health strategy.


Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market
Sydney Bondi Beach Shooting Sparks Calls for Stronger Protection of Jewish Community in Australia
Trump Administration Moves to Keep TransAlta Coal Plant Running Amid Rising AI Power Demand
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper
Supporters Gather Ahead of Verdict in Jimmy Lai’s Landmark Hong Kong National Security Trial
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Jimmy Lai Convicted Under Hong Kong National Security Law in Landmark Case
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids
Lukashenko Urges Swift Ukraine Peace Deal, Backs Trump’s Push for Rapid Resolution 



